Biologics Reshape Treatment of Eosinophilic Esophagitis in Children
Monoclonal antibody therapy, led by dupilumab, is transforming the treatment of eosinophilic esophagitis in children after decades of limited options.
Monoclonal antibody therapy, led by dupilumab, is transforming the treatment of eosinophilic esophagitis in children after decades of limited options.
A scoping review screened more than 3,500 records and found only three quantitative studies worldwide on self-stigma of mental illness ...
A survey of 734 Hungarian in-service teachers found that misconceptions about motor development and coordination are highly prevalent, and that ...
Children with relapsed leukemia and solid tumors increasingly survive because of a new generation of cancer immunotherapies — CAR-T cells, ...
A cross-sectional study of 550 South African rheumatoid arthritis patients reveals that 27.5% rate their disease activity higher than their ...
The appeal of hydrogels in regenerative medicine begins with a deceptively simple physical observation: soft tissues of the human body ...
A new hybrid framework combining LLM-assisted accident coding, Monte Carlo simulation, and decision tree analysis shows that human and organizational ...
In a finding that could reshape how doctors think about high blood pressure in the young, a research team in ...
The distinction between technological deficit and multidimensional readiness gap carries significant weight for how development resources might be allocated in ...
Deep in the shaded streams of southern Switzerland, a small predatory bug has been quietly evading scientists for more than ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine